Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1632, 2008-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Genomics could spell end to inequities in global healthcare?
Inpharma, Vol. 1, Iss. 1337, 2002-01 ,pp. :
Access to resources
Recommend
Second generation DM programmes spell success?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 372, 2002-01 ,pp. :
Ezetimibe and cancer: stormy SEAS calmed by fresh analysis?
Inpharma, Vol. 1, Iss. 1655, 2008-01 ,pp. :
Ezetimibe/simvastatin: the elite LDL-cholesterol lowering entity?
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. :